Matinas BioPharma Holdings, Inc.
MTNB
$0.75
-$0.06-7.19%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.44M | 6.53M | 6.92M | 7.28M | 10.80M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 168.00K | 693.00K | 573.00K | 691.00K | 896.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K |
| Total Current Assets | 5.65M | 7.27M | 7.55M | 8.03M | 11.74M |
|
|
|||||
| Total Current Assets | 5.65M | 7.27M | 7.55M | 8.03M | 11.74M |
| Net Property, Plant & Equipment | 1.51M | 1.63M | 2.03M | 2.16M | 4.28M |
| Long-term Investments | -- | -- | -- | -- | 1.34M |
| Goodwill | -- | -- | -- | -- | 1.34M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.53M | 2.53M | 2.46M | 2.46M | 3.22M |
| Total Assets | 9.70M | 11.42M | 12.04M | 12.64M | 20.58M |
|
|
|||||
| Total Accounts Payable | 80.00K | 167.00K | 282.00K | 95.00K | 349.00K |
| Total Accrued Expenses | 564.00K | 795.00K | 1.18M | 1.81M | 1.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 851.00K | 822.00K | 794.00K | 766.00K | 738.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.50M | 1.78M | 2.26M | 2.67M | 2.12M |
|
|
|||||
| Total Current Liabilities | 1.50M | 1.78M | 2.26M | 2.67M | 2.12M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.48M | 1.71M | 1.92M | 2.13M | 2.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 257.00K | 257.00K | 1.59M | 257.00K | 341.00K |
| Total Liabilities | 3.24M | 3.75M | 5.77M | 5.05M | 4.80M |
|
|
|||||
| Common Stock & APIC | 215.34M | 214.40M | 207.75M | 207.41M | 207.17M |
| Retained Earnings | -208.88M | -206.73M | -201.48M | -199.82M | -191.39M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 6.46M | 7.68M | 6.27M | 7.59M | 15.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.46M | 7.68M | 6.27M | 7.59M | 15.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.46M | 7.68M | 6.27M | 7.59M | 15.78M |
|
|
|||||